PFCA
Showing 1 - 4 of 4
Plasmodium Falciparum Trial run by the (NMRC-M3V-Ad-PfCA, NMRC-MV-Ad-PfC, NMRC-M3V-Ad-PfCA)
Completed
- Plasmodium Falciparum
- NMRC-M3V-Ad-PfCA
- NMRC-MV-Ad-PfC, NMRC-M3V-Ad-PfCA
-
Bethesda, MarylandNaval Medical Research Center (NMRC) Clinical Trials Center
Apr 28, 2021
Atrial Fibrillation Trial (Atrial ablation for subject scheduled for a de novo endocardial ablation of symptomatic,
Recruiting
- Atrial Fibrillation
- Atrial ablation for subject scheduled for a de novo endocardial ablation of symptomatic, drug-refractory PsAF.
-
Montréal, Quebec, Canada
- +1 more
Dec 13, 2022
Malaria Trial in Bethesda, Silver Spring (D/ChAd63-CA, D/ChAd63-CAT, Infectivity Control (IC) Group)
Completed
- Malaria
- D/ChAd63-CA
- +2 more
-
Bethesda, Maryland
- +1 more
May 5, 2020
Healthy, Malaria Trial run by the (Ad-PfCA)
Withdrawn
- Healthy
- Malaria
- Ad-PfCA
-
Bethesda, MarylandNaval Medical Research Center Clinical Trials Center
Apr 28, 2015